T1	p 309 314	HIV-1
T2	p 328 378	from HIV-1-infected women to their male partners .
T3	p 430 497	3790 heterosexual HIV-1-serodiscordant couples participating in two
T4	p 541 566	seven African countries .
T5	p 690 695	HIV-1
T6	p 714 728	women to men .
T7	p 935 947	1314 couples
T8	p 980 1007	partner was female ( median
T9	p 1110 1127	in women who used
T10	p 1270 1282	2476 couples
T11	p 1315 1340	partner was male ( median
T12	p 1418 1440	women to men were 2?61
T13	p 1465 1481	couples in which
T14	p 1549 1571	couples in which women
T15	p 2036 2037	.
T16	p 2119 2132	women with or
T17	p 2202 2233	Bill & Melinda Gates Foundation
T18	i 13 36	hormonal contraceptives
T19	i 110 133	Hormonal contraceptives
T20	i 239 261	hormonal contraceptive
T21	i 430 434	3790
T22	i 588 621	oral hormonal contraceptive users
T23	i 886 899	contraceptive
T24	i 1128 1150	hormonal contraception
T25	i 1493 1515	hormonal contraception
T26	i 1584 1606	hormonal contraception
T27	i 1899 1907	hormonal
T28	i 2038 2085	Non-hormonal or low-dose hormonal contraceptive
T29	i 2133 2140	at-risk
T30	o 275 295	of HIV-1 acquisition
T31	o 528 537	incidence
T32	o 656 676	of HIV-1 acquisition
T33	o 761 781	HIV-1 seroconversion
T34	o 809 827	hazards regression
T35	o 1052 1078	rates of HIV-1 acquisition
T36	o 1385 1390	rates
T37	o 1394 1399	HIV-1
T38	o 1856 1876	of HIV-1 acquisition
T39	o 2005 2012	condoms
T40	o 2184 2197	of Health and